What is - Excellent performance status (PS 0)
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Based on the clinical summary document, let me explain the significance of Feby Reali's "Performance Status: 0" (PS 0):
According to ASCO (American Society of Clinical Oncology) guidelines and ECOG (Eastern Cooperative Oncology Group) Performance Status scale:
A Performance Status of 0 means:
- The patient is fully active
- Able to carry out all pre-disease activities without restriction
- Capable of normal function without limitations
- Can perform normal daily activities without assistance
This is particularly significant because, as noted in the NCCN Guidelines for Central Nervous System Cancers, performance status is:
- A critical factor in determining treatment options
- An important prognostic indicator
- A key consideration for clinical trial eligibility
In Feby's specific case, the document notes this excellent performance status despite:
- Having recurrent glioblastoma
- Multiple surgical resections
- Recent complications including seizures and intratumoral bleeding
- Progressive multifocal disease
This good performance status is particularly noteworthy as the National Cancer Institute (NCI) guidelines indicate that maintaining a high performance status can:
- Allow for more aggressive treatment options
- Better tolerance of therapeutic interventions
- Improved quality of life
- Better overall prognosis compared to patients with poorer performance status
However, it's important to note that performance status can change over time, and regular reassessment is necessary, especially given the document's indication of disease progression.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ